Postoperative Hypofractionated Radiotherapy for Thymic Epithelial Tumors: Efficacy and Safety Results from a Prospective, Single-Center, Phase II Trial
International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · S70
DOI: 10.1016/j.ijrobp.2026.06.070 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von T. Zhang und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zhang, T., Zhang, Z., Gao, D., Guo, X., & Bi, N. (2026). Postoperative Hypofractionated Radiotherapy for Thymic Epithelial Tumors: Efficacy and Safety Results from a Prospective, Single-Center, Phase II Trial. International Journal of Radiation Oncology*Biology*Physics, 126(1), S70. https://doi.org/10.1016/j.ijrobp.2026.06.070
Vancouver
Zhang T, Zhang Z, Gao D, Guo X, Bi N. Postoperative Hypofractionated Radiotherapy for Thymic Epithelial Tumors: Efficacy and Safety Results from a Prospective, Single-Center, Phase II Trial. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):S70. doi:10.1016/j.ijrobp.2026.06.070
BibTeX
@article{Zhang2026,
author = {Zhang, T. and Zhang, Z. and Gao, D. and Guo, X. and Bi, N.},
title = {Postoperative Hypofractionated Radiotherapy for Thymic Epithelial Tumors: Efficacy and Safety Results from a Prospective, Single-Center, Phase II Trial},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {126},
number = {1},
pages = {S70},
doi = {10.1016/j.ijrobp.2026.06.070}
}
EUVIMED